Kemin Foods LC
9
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
11.1%
1 terminated/withdrawn out of 9 trials
88.9%
+2.4% vs industry average
0%
0 trials in Phase 3/4
13%
1 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Investigational Test of a New Sleep Supplement
Role: collaborator
Effects of an Encapsulated Calcium Butyrate Dietary Supplement on Gut Health
Role: lead
Ability of Beta-glucan Supplementation to Augment Immune Function
Role: lead
Evaluation of the Benefits of FloraGLO™ Lutein on Skin Health
Role: lead
Efficacy of a Whole Cell Algae Fermentate on Gut Health and Overall Immune Function in Healthy Adults With Mild Gastrointestinal Issues
Role: lead
Effects of Lutein on Visual Function
Role: lead
Ability of a Euglena Beta Glucan Supplementation to Augment Immune Function
Role: lead
The Effects of A Proprietary Spearmint Extract on Cognitive Performance
Role: lead
The Effect of XSurge Supplementation on Biomarkers and Performance From High Intensity Resistance Exercise
Role: lead
All 9 trials loaded